Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro

Infection and Immunity

Volumn 64, Issue 3, 1996, Pages 1011-1015

  Hirohashi, Nobuyuki ^a,c   Morrison, David C ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; INTERLEUKIN 6; NITRIC OXIDE; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 0030051294     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.3.1011-1015.1996     Document Type: Article

References (31)

1. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med 179:1895-1902
2. Cavaillon, J.-M., C. Pitton, and C. Fitting. 1994. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10, and TGFβ. J. Endotoxin Res. 1:21-29.
3. Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:271-277.
4. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages J. Immunol. 141:2407.
5. Drapier, J.-C., J. Wietzerbin, and J. B. Hibbs, Jr. 1988. Interferon γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18:1587-1592.
6. Fahmi, H., and R. Chaby. 1993 Desensitization of macrophages to endotoxin effects is not correlated with a down-regulation of lipopolysaccharide-binding sites. Cell. Immunol. 150:219-229.
7. Haas, J. G., P. A. Baeuerle, G. Riethmuller, and H. W. L. Ziegler-Heitbrock. 1990. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl. Acad. Sci. USA 87:9563-9567.
8. 7a.Hirohashi, N., and D. C. Morrison. Unpublished data.
9. Jia, F., D. C. Morrison, and R. Silverstein. 1994. Hydrazine sulfate selectively modulates the TNF response to endotoxin in mouse macrophages Circ. Shock 42:111-114.
10. Knopf, H.-P., F. Otto, R. Engelhardt, M. A. Freudenberg, C. Galanos, F. Herrmann, and R. R. Schumann. 1994. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. J. Immunol. 153:287-306.
11. Kunkel, S. L., R. C. Wiggins, S. W. Chensue, and J. Larrick. 1986. Regulation of macrophage tumor necrosis factor production by prostaglandin E2 Biochem. Biophys. Res. Commun. 137:404-410.
12. LaRue, E. E. A., and C. E. McCall. 1994. A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180:2269-2275.
13. Li, M. H., S. C. Seatter, R. Manthei, M. Bubrick, and M. A. West. 1994. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J. Surg. Res 57:85-92
14. Mathison, J., E. Wolfson, S. Steinemann, P. Tobias, and R. J. Ulevitch. 1993. Lipopolysaccharide (LPS) recognition in macrophages - participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J. Clin. Invest. 92:2053-2059.
15. Mathison, J. C., G. D. Virca, E. Wolfson, P. S. Tobias, K. Glaser, and R. J. Ulevitch. 1990. Adaptation to bacterial lipopolysaccharide control lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages J. Clin. Invest. 85:1108-1118.
16. Mengozzi, M., G. Fantuzzi, M. Sironi, M. Bianchi, M. Fratelli, G. Peri, S. Bernasconi, and P. Ghezzi. 1993. Early down-regulation of TNF production by LPS tolerance in human monocytes. comparison with IL-1β, IL-6. and IL-8. Lymphokine Cytokine Res. 12:231-236.
17. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med 38:417-432
18. Pabst, M. J., and R. B. Johnston. 1980. Increased production of Superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J. Exp Med 151:101-114
19. Parmely, M. J., W.-W. Zhou, C. K. Edwards, D. R. Borcherding, R. Silverstein, and D. C. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389-396.
20. 2 and cyclic nucleotides. J. Immunol. 141:2388-2393.
21. Ruff, M. R., and G. E. Gifford. 1980. Purification and physiochemical characterization of rabbit tumor necrosis factor. J Immunol. 125:1671-1677.
22. Siegel, S. A., D. J. Shealy, M. T. Nakada, J. Le, D. S. Woulfe, L. Probert, G. Kollias, J. Grayeb, J. Vilcek, and P. E. Daddona. 1995 The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine 7:15-25.
23. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide; a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med 169:1543-1555.
24. Takatsuka, N., T. Tokunaga, and K. S. Akagawa. 1991. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J. Immunol. 146:3824-2830.
25. 2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B cell hybridomas. Proc. Natl. Acad. Sci. USA 82:9679-9683.
26. Virca, G. D., S. Y. Kim, K. B. Glaser, and K. J. Ulevitch. 1989. Lipopolysaccharide induced hyporesponsiveness to its own action in RAW 246.7 cells. J. Biol. Chem. 264:21951-21956.
27. Zhang, X., E. W. Alley, S. W. Russell, and D. C. Morrison. 1994. Necessity and sufficiency of beta Interferon for nitric oxide production in mouse peritoneal macrophages. Infect. Immun. 62:33-40.
28. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on TNF-α and nitric oxide production. J. Exp. Med 177:511-516.
29. Zhang, X., and D. C. Morrison. 1993. Pertussis toxin-sensitive factor differentially regulates lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production in mouse peritoneal macrophages. J. Immunol. 150:1011-1018.
30. Zhang, X., and D. C. Morrison. 1993. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukocyte Biol. 54:444-450.
31. Ziegler-Heitbrock, H. W. L., M. Blumenstein, E. Kafferlein, D. Kieper, I. Petersmann, S. Endres, W. A. Flegel, H. Northoff, G. Riethmuller, and J. G. Haas. 1992. In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology 75:264-268.